vs

Side-by-side financial comparison of ARVINAS, INC. (ARVN) and RE/MAX Holdings, Inc. (RMAX). Click either name above to swap in a different company.

RE/MAX Holdings, Inc. is the larger business by last-quarter revenue ($71.1M vs $41.9M, roughly 1.7× ARVINAS, INC.). RE/MAX Holdings, Inc. runs the higher net margin — 2.0% vs -83.8%, a 85.8% gap on every dollar of revenue. On growth, RE/MAX Holdings, Inc. posted the faster year-over-year revenue change (-1.8% vs -59.1%). RE/MAX Holdings, Inc. produced more free cash flow last quarter ($33.5M vs $-59.2M). Over the past eight quarters, ARVINAS, INC.'s revenue compounded faster (10.0% CAGR vs -4.7%).

Arvinas, Inc. is a clinical-stage biotechnology company focused on developing targeted protein degradation therapies, including PROTAC molecules, to treat cancer and rare diseases. It operates primarily in the U.S. and global biopharma markets, advancing multiple pipeline candidates through clinical trials to address unmet medical needs.

RE/MAX is an international real estate franchise operating in over 100 countries and territories that, in 2015, had over 100,000 agents in 6,800 offices.

ARVN vs RMAX — Head-to-Head

Bigger by revenue
RMAX
RMAX
1.7× larger
RMAX
$71.1M
$41.9M
ARVN
Growing faster (revenue YoY)
RMAX
RMAX
+57.2% gap
RMAX
-1.8%
-59.1%
ARVN
Higher net margin
RMAX
RMAX
85.8% more per $
RMAX
2.0%
-83.8%
ARVN
More free cash flow
RMAX
RMAX
$92.7M more FCF
RMAX
$33.5M
$-59.2M
ARVN
Faster 2-yr revenue CAGR
ARVN
ARVN
Annualised
ARVN
10.0%
-4.7%
RMAX

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
ARVN
ARVN
RMAX
RMAX
Revenue
$41.9M
$71.1M
Net Profit
$-35.1M
$1.4M
Gross Margin
Operating Margin
-104.5%
13.1%
Net Margin
-83.8%
2.0%
Revenue YoY
-59.1%
-1.8%
Net Profit YoY
28.7%
-75.2%
EPS (diluted)
$-0.48

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ARVN
ARVN
RMAX
RMAX
Q4 25
$71.1M
Q3 25
$41.9M
$73.2M
Q2 25
$72.8M
Q1 25
$188.8M
$74.5M
Q4 24
$59.2M
$72.5M
Q3 24
$102.4M
$78.5M
Q2 24
$76.5M
$78.5M
Q1 24
$25.3M
$78.3M
Net Profit
ARVN
ARVN
RMAX
RMAX
Q4 25
$1.4M
Q3 25
$-35.1M
$4.0M
Q2 25
$4.7M
Q1 25
$82.9M
$-2.0M
Q4 24
$-45.1M
$5.8M
Q3 24
$-49.2M
$966.0K
Q2 24
$-35.2M
$3.7M
Q1 24
$-69.4M
$-3.4M
Operating Margin
ARVN
ARVN
RMAX
RMAX
Q4 25
13.1%
Q3 25
-104.5%
25.0%
Q2 25
19.3%
Q1 25
37.8%
7.2%
Q4 24
-98.1%
5.9%
Q3 24
-58.9%
19.4%
Q2 24
-63.4%
20.6%
Q1 24
-329.2%
5.8%
Net Margin
ARVN
ARVN
RMAX
RMAX
Q4 25
2.0%
Q3 25
-83.8%
5.4%
Q2 25
6.4%
Q1 25
43.9%
-2.6%
Q4 24
-76.2%
8.0%
Q3 24
-48.0%
1.2%
Q2 24
-46.0%
4.7%
Q1 24
-274.3%
-4.3%
EPS (diluted)
ARVN
ARVN
RMAX
RMAX
Q4 25
Q3 25
$-0.48
Q2 25
Q1 25
$1.14
Q4 24
$-0.63
Q3 24
$-0.68
Q2 24
$-0.49
Q1 24
$-0.97

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ARVN
ARVN
RMAX
RMAX
Cash + ST InvestmentsLiquidity on hand
$787.6M
$118.7M
Total DebtLower is stronger
$600.0K
$432.2M
Stockholders' EquityBook value
$564.4M
$452.4M
Total Assets
$844.3M
$582.5M
Debt / EquityLower = less leverage
0.00×
0.96×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ARVN
ARVN
RMAX
RMAX
Q4 25
$118.7M
Q3 25
$787.6M
$107.5M
Q2 25
$94.3M
Q1 25
$954.3M
$89.1M
Q4 24
$1.0B
$96.6M
Q3 24
$1.1B
$83.8M
Q2 24
$1.2B
$66.1M
Q1 24
$1.2B
$82.1M
Total Debt
ARVN
ARVN
RMAX
RMAX
Q4 25
$432.2M
Q3 25
$600.0K
$433.3M
Q2 25
$434.4M
Q1 25
$700.0K
$435.3M
Q4 24
$800.0K
$436.2M
Q3 24
$800.0K
$437.2M
Q2 24
$900.0K
$438.1M
Q1 24
$900.0K
$439.0M
Stockholders' Equity
ARVN
ARVN
RMAX
RMAX
Q4 25
$452.4M
Q3 25
$564.4M
$448.1M
Q2 25
$442.4M
Q1 25
$660.1M
$433.5M
Q4 24
$561.7M
$429.5M
Q3 24
$586.0M
$423.1M
Q2 24
$600.2M
$418.4M
Q1 24
$609.7M
$412.0M
Total Assets
ARVN
ARVN
RMAX
RMAX
Q4 25
$582.5M
Q3 25
$844.3M
$582.2M
Q2 25
$574.8M
Q1 25
$1.0B
$571.4M
Q4 24
$1.1B
$581.6M
Q3 24
$1.2B
$578.6M
Q2 24
$1.3B
$571.4M
Q1 24
$1.2B
$566.7M
Debt / Equity
ARVN
ARVN
RMAX
RMAX
Q4 25
0.96×
Q3 25
0.00×
0.97×
Q2 25
0.98×
Q1 25
0.00×
1.00×
Q4 24
0.00×
1.02×
Q3 24
0.00×
1.03×
Q2 24
0.00×
1.05×
Q1 24
0.00×
1.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ARVN
ARVN
RMAX
RMAX
Operating Cash FlowLast quarter
$-59.1M
$40.9M
Free Cash FlowOCF − Capex
$-59.2M
$33.5M
FCF MarginFCF / Revenue
-141.3%
47.1%
Capex IntensityCapex / Revenue
0.2%
10.4%
Cash ConversionOCF / Net Profit
28.39×
TTM Free Cash FlowTrailing 4 quarters
$-361.6M
$56.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ARVN
ARVN
RMAX
RMAX
Q4 25
$40.9M
Q3 25
$-59.1M
$17.7M
Q2 25
$4.6M
Q1 25
$-88.9M
$5.7M
Q4 24
$-84.1M
$59.7M
Q3 24
$-128.0M
$17.6M
Q2 24
$50.3M
$15.9M
Q1 24
$-97.5M
$9.4M
Free Cash Flow
ARVN
ARVN
RMAX
RMAX
Q4 25
$33.5M
Q3 25
$-59.2M
$16.4M
Q2 25
$2.9M
Q1 25
$-89.3M
$4.0M
Q4 24
$-84.4M
$53.0M
Q3 24
$-128.7M
$16.3M
Q2 24
$49.6M
$14.0M
Q1 24
$-97.6M
$6.8M
FCF Margin
ARVN
ARVN
RMAX
RMAX
Q4 25
47.1%
Q3 25
-141.3%
22.4%
Q2 25
4.0%
Q1 25
-47.3%
5.3%
Q4 24
-142.6%
73.2%
Q3 24
-125.7%
20.8%
Q2 24
64.8%
17.8%
Q1 24
-385.8%
8.6%
Capex Intensity
ARVN
ARVN
RMAX
RMAX
Q4 25
10.4%
Q3 25
0.2%
1.8%
Q2 25
2.2%
Q1 25
0.2%
2.3%
Q4 24
0.5%
9.1%
Q3 24
0.7%
1.7%
Q2 24
0.9%
2.4%
Q1 24
0.4%
3.3%
Cash Conversion
ARVN
ARVN
RMAX
RMAX
Q4 25
28.39×
Q3 25
4.45×
Q2 25
0.97×
Q1 25
-1.07×
Q4 24
10.28×
Q3 24
18.22×
Q2 24
4.29×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ARVN
ARVN

Segment breakdown not available.

RMAX
RMAX

Franchising Segment$50.1M70%
Broker Fees$13.9M20%
Annual Dues$7.4M10%

Related Comparisons